Valuation
- Market cap
- 19,638,000
- Revenue TTM
- $770,000
- Net income TTM
- $-3,200,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -415.58%
- Debt to equity
- -0.12
Trading
- Volume
- 15,600
- Avg volume
- 28,484
- Day's range
- $0.18 – $0.20
- Shares out
- 98,188,000
- Stochastic %K
- 13%
- Beta
- 0.70
- Analysts
- Strong Buy
- Price target
- —
Company profile
Guided Therapeutics, Inc., a medical technology company, researches, develops, tests, manufactures, sells, and distributes medical devices in the United States and internationally. It offers LuViva, an advanced cervical scan non-invasive cervical cancer detection device that provides less invasive and painless alternative to conventional tests for identifying, screening, and detecting cervical cancers and precancers....
Show more
Guided Therapeutics, Inc., a medical technology company, researches, develops, tests, manufactures, sells, and distributes medical devices in the United States and internationally. It offers LuViva, an advanced cervical scan non-invasive cervical cancer detection device that provides less invasive and painless alternative to conventional tests for identifying, screening, and detecting cervical cancers and precancers. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is headquartered in Peachtree Corners, Georgia.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 770 242 8723
- Website
- https://www.guidedinc.com
- Address
- 5835 Peachtree Corners East, Suite B, Peachtree Corners, United States
Latest news
No headlines yet.
